ACTRN12623000258651尚未招募3 期
Evaluation of the sublingual vaccination MV140 in the prevention of recurrent urinary tract infections in the older adult Australian population - a multi-centre, double-blinded, randomised controlled trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •People aged greater than or equal to 65-years of any gender
- •Recurrent UTI (defined as 3 or more UTIs within the last 12 months)
- •Competence to consent to participate in trial and comply with study requirements
排除标准
- •History of bladder tumours
- •Diagnosed bladder fistula disease
- •Currently receiving immunotherapy for another condition
- •Any immunological disease requiring active treatment
- •Known intolerance/allergy to MV140 or ingredients it contains
- •Known bladder stones
- •Long-term urinary catheter dependence (IDC/SPC)
- •Unable to provide informed consent or meet study requirements
研究者
相似试验
已完成
2 期
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase IIAsthmaRPCEC00000125ational Center of Bioproducts (BioCen)300
招募中
不适用
Sublingual Immunotherapy Effect on Allergic RhinitisIRCT20171105037262N1Kashan University of Medical Sciences90
招募中
不适用
Efficacy and Safety of Sequential Sublingual Immunotherapy with Japanese Ceder Pollen and House Dust Mite allergensallergic rhinitisJPRN-UMIN000036469Shiga University of Medical Science184
进行中（未招募）
不适用
A study, which aims to evaluate the efficacy and safety of LAIS® Birch-Alder tablets in patients suffering from allergic inflammation of the conjunctiva and rhinitis caused by birch pollePatients suffering from allergic rhinoconjunctivitisMedDRA version: 17.1Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853EUCTR2013-002129-43-DEofarma S.p.A.
进行中（未招募）
1 期
Efficacy and Safety of sublingual immunotherapy with Allergoid LAIS Birch tablets for patients with tree pollen-induced allergic rhinoconjunctivitis with or without mild controlled asthmaEUCTR2018-002596-18-ITOFARMA S.P.A.110